Clinical Trial Update: Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA) [Phase 2]

View source ↗

Summary

A Phase 2 study investigating DHP1401 in patients with mild-to-moderate Alzheimer's disease treated with donepezil has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• DHP1401 (DHP1401)
• Donepezil (donepezil)

Snippet

Sponsor: Daehwa Pharmaceutical Co., Ltd. | Conditions: Mild-moderate Alzheimer's Disease | Phase 2 | Status: COMPLETED